Improving safety practices for oncology nurses handling chemotherapy
Official title: Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses
Funded at University of Cincinnati · NIH-10784024 · Data updated 2026-11-12
This study is working to keep oncology nurses safe by creating a new program called WISH that teaches them how to handle chemotherapy safely and helps them talk about any issues they face, so they can better protect themselves while caring for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $106,792 |
| NIH project number | 1K01OH012671-01 |
| Project ID | NIH-10784024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are oncology nurses who handle chemotherapy drugs in their workplace.
✕Less likely to help
Patients who are not oncology nurses or do not work in environments where chemotherapy is handled will not benefit from this research.
What this research studies
This research aims to enhance the safety of oncology nurses by promoting adherence to chemotherapy handling guidelines. It involves developing a novel program called WISH, which includes an educational component and debriefing sessions to address chemotherapy exposure incidents. The program will be validated through expert evaluations and focus groups with oncology nurses to ensure its effectiveness and relevance. By improving adherence to safety protocols, the research seeks to reduce the risks associated with chemotherapy exposure for nurses.
Why it matters
Potential benefit: If successful, this research could significantly reduce the occupational hazards faced by oncology nurses, leading to improved health outcomes.
How similar studies have gone: While there may be existing programs aimed at improving safety in healthcare settings, this specific approach to enhancing chemotherapy handling guidelines among oncology nurses is relatively novel.
Where this research is happening
-
University of Cincinnati
Cincinnati, United States Active
Researchers
- Principal investigator: Abu-Alhaija, Dania — University of Cincinnati
- Study coordinator: Abu-Alhaija, Dania
Related research
Other NIH-funded projects on the same topics.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Dual targeting of heart cell receptors to prevent chemotherapy heart damage
Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
-
Genetic clues for doxorubicin heart risk using patient-derived heart cells
A research project tests how human heart cells grown from stem cells react to a common chemotherapy to see which genetic differences may raise the risk of heart damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.